Prothiaden: Effective Relief for Major Depressive Disorder
| Product dosage: 75 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.83 | $49.88 (0%) | 🛒 Add to cart |
| 90 | $0.76 | $74.82 $68.80 (8%) | 🛒 Add to cart |
| 120 | $0.66 | $99.76 $79.12 (21%) | 🛒 Add to cart |
| 180 | $0.63
Best per pill | $149.64 $112.66 (25%) | 🛒 Add to cart |
Synonyms | |||
Prothiaden (dothiepin hydrochloride) is a tricyclic antidepressant (TCA) indicated for the treatment of major depressive disorder. It functions by inhibiting the reuptake of norepinephrine and serotonin in the central nervous system, thereby restoring neurotransmitter balance and alleviating depressive symptoms. With a well-established efficacy profile, it is prescribed for moderate to severe depression, particularly in cases where other antidepressants have been ineffective or poorly tolerated. Its sedative properties also make it suitable for patients experiencing significant insomnia or agitation as part of their depressive symptomatology.
Features
- Active ingredient: Dothiepin hydrochloride
- Available in 25 mg and 75 mg tablet formulations
- Dual mechanism: serotonin and norepinephrine reuptake inhibition
- Long half-life allowing for once-daily dosing in maintenance phase
- Demonstrated efficacy in both acute and maintenance treatment of depression
Benefits
- Provides significant relief from core depressive symptoms such as low mood, anhedonia, and fatigue
- Improves sleep architecture, reducing insomnia and early morning awakening
- Reduces anxiety and somatic symptoms frequently associated with depression
- Supports functional recovery and return to daily activities
- Offers a therapeutic option for treatment-resistant depression
- May be beneficial in certain chronic pain conditions due to its neuromodulatory effects
Common use
Prothiaden is primarily indicated for the management of major depressive disorder. It is used in adult patients presenting with persistent low mood, loss of interest, sleep disturbances, changes in appetite, and impaired concentration. It may also be prescribed off-label for certain anxiety disorders, neuropathic pain, and migraine prophylaxis, though these uses are supported by less robust clinical evidence. Treatment is typically initiated after a thorough psychiatric and medical evaluation to ensure appropriateness.
Dosage and direction
The initial dosage for adults is typically 75 mg daily, administered orally, usually in divided doses or as a single nighttime dose to capitalize on its sedative effects. Dosage may be gradually increased under medical supervision to a maximum of 150 mg per day, based on therapeutic response and tolerability. Elderly patients or those with hepatic impairment should start at a lower dose, often 25–50 mg daily. Maintenance therapy is generally continued for at least 6 months after symptom remission to prevent relapse. Abrupt discontinuation should be avoided; instead, doses should be tapered gradually over several weeks.
Precautions
Patients should be monitored for emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, and hypomania, particularly during initial treatment or dose adjustments. Use with caution in patients with cardiovascular disease, due to risk of orthostatic hypotension, tachycardia, and conduction abnormalities. Regular ECG monitoring may be advisable in susceptible individuals. Prothiaden may impair cognitive and motor performance; patients should avoid driving or operating machinery until they know how the medication affects them. Caution is advised in patients with a history of seizures, narrow-angle glaucoma, or urinary retention.
Contraindications
Prothiaden is contraindicated in patients with known hypersensitivity to dothiepin or other tricyclic antidepressants. It must not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to risk of serotonin syndrome. Additional contraindications include recent myocardial infarction, severe liver impairment, and mania or hypomania. It is not recommended during the acute recovery phase after myocardial infarction or in patients with severe conduction disorders.
Possible side effects
Common adverse reactions include dry mouth, constipation, blurred vision, drowsiness, dizziness, and weight gain. Less frequently, patients may experience orthostatic hypotension, increased sweating, urinary retention, and sexual dysfunction. Serious but rare side effects include cardiac arrhythmias, seizures, hyponatremia, and blood dyscrasias. Any signs of allergic reaction, such as rash, swelling, or difficulty breathing, warrant immediate medical attention.
Drug interaction
Prothiaden interacts with numerous medications. Concomitant use with SSRIs, SNRIs, triptans, or other serotonergic drugs increases the risk of serotonin syndrome. It may potentiate the effects of CNS depressants including alcohol, benzodiazepines, and opioids. Anticholinergic effects may be enhanced when used with other anticholinergic drugs. Concurrent use with antihypertensives may increase the risk of hypotension. It may also interact with anticoagulants, anticonvulsants, and certain antipsychotics. A comprehensive medication review is essential before initiation.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended, as it may increase the risk of adverse effects.
Overdose
Overdose with Prothiaden can be life-threatening and may present with symptoms such as severe drowsiness, confusion, agitation, hallucinations, tachycardia, hypotension, respiratory depression, seizures, and cardiac arrhythmias. ECG monitoring is essential. Treatment is supportive and may include gastric lavage, activated charcoal, and management of specific symptoms such as arrhythmias or seizures. There is no specific antidote; immediate medical attention is critical.
Storage
Store at room temperature (15–30°C), in a dry place, protected from light and moisture. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging. Unused medication should be disposed of properly via a pharmacy take-back program and not flushed or thrown in household trash.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication regimen. Individual response to Prothiaden may vary, and only a prescribing physician can determine its appropriateness based on a patient’s specific health profile.
Reviews
Clinical studies and post-marketing surveillance indicate that Prothiaden is effective in reducing depressive symptoms, with many patients reporting improved mood, sleep, and overall functioning within 4–6 weeks of treatment. Some users note sedation and anticholinergic side effects as drawbacks, though these often diminish over time. It remains a valued option in psychiatric practice, particularly for cases where newer antidepressants have proven insufficient.